Given that decreased APOBEC3A levels were observed as CES‐R/M group‐specific features and as unfavorable clinical outcome‐predicting features, it is assumed the APOBEC activity is repressed in metastatic tumors and may predict the disease progression and metastasis in CES with HPV infection. This evidence concerns the gene APOBEC3A and metastatic neoplasm.